Effects of eldecalcitol on cortical bone response to mechanical loading in rats

BMC Musculoskeletal Disorders

Hiroshi Hagino³  Hideki Nagashima¹  Mari Osaki⁴  Keita Nagira¹  Yusuke Yamasaki² 

[1] Department of Orthopedic Surgery, Faculty of Medicine, Tottori University, Yonago, Japan;YMCA College of Medical & Human Services in Yonago, Yonago, Japan;School of Health Science, Faculty of Medicine, Tottori University, Yonago, Japan;Rehabilitation Division of Tottori University Hospital, Yonago, Japan

关键词: Four-point bending;    Bone formation;    Mechanical loading;    Eldecalcitol;   

Others  :  1227736
DOI  :  10.1186/s12891-015-0613-3

 received in 2015-01-16, accepted in 2015-06-01,  发布年份 2015

【 摘 要 】

Background

Mechanical loading of bones activates modeling and suppresses remodeling by promoting bone formation. Eldecalcitol is approved for the treatment of osteoporosis in Japan and is often used in patients undergoing exercise therapy. However, the effects of eldecalcitol on bone formation during mechanical loading are unknown. The aim of this study was to clarify the influence of eldecalcitol administration on bone response to mechanical loading using a four-point bending device.

Methods

Forty six-month-old female Wistar rats were randomized into four groups based on eldecalcitol dose (vehicle administration (VEH), low dose (ED-L), medium dose (ED-M), and high dose (ED-H)). Loads of 38 N were applied in vivo to the right tibia for 36 cycles at 2 Hz, by four-point bending, 3 days per week for 3 weeks. After calcein double-labeling, rats were sacrificed and tibial cross sections were prepared from the region with maximal bending at the central diaphysis. Histomorphometry was performed on the entire periosteal and endocortical surface of the tibiae, dividing the periosteum into lateral and medial surfaces.

Results

The effects of external loading on bone formation parameters were significant at all three surfaces. Bone formation parameters were highest in the ED-H group, and the effects of eldecalcitol on bone formation rate were significant at the endocortical surface. In addition, the interaction between loading and eldecalcitol dose significantly affected bone formation rate at the endocortical surface.

Conclusions

Eldecalcitol enhanced the cortical bone response to mechanical loading and a synergistic effect was observed in a rat model.

【 授权许可】

   
2015 Yamasaki et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

【 参考文献 】

• [1]Ono Y. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol’s benefit in osteoporosis treatment. J Steroid Biochem Mol Biol. 2014; 139:88-97.
• [2]Matsumoto T, Miki T, Hagino H, Sugimoto T, Okamoto S, Hirota T et al.. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2005; 90(9):5031-5036.
• [3]Matsumoto T, Ito M, Hayashi Y, Hirota T, Tanigawara Y, Sone T et al.. A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures–a randomized, active comparator, double-blind study. Bone. 2011; 49(4):605-612.
• [4]Sakai S, Takaishi H, Matsuzaki K, Kaneko H, Furukawa M, Miyauchi Y et al.. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. J Bone Miner Metab. 2009; 27(6):643-652.
• [5]Ueno Y, Shinki T, Nagai Y, Murayama H, Fujii K, Suda T. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH. J Cell Biochem. 2003; 90(2):267-277.
• [6]Harada S, Mizoguchi T, Kobayashi Y, Nakamichi Y, Takeda S, Sakai S et al.. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone. J Bone Miner Res. 2012; 27(2):461-473.
• [7]Tsurukami H, Nakamura T, Suzuki K, Sato K, Higuchi Y, Nishii Y. A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcif Tissue Int. 1994; 54(2):142-149.
• [8]Uchiyama Y, Higuch IY, Takeda S, Masaki T, Shira-Ishi A, Sato K et al.. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone. 2002; 30(4):582-588.
• [9]Martin RB BD. Structure, function, and adaptation of compact bone. Raven, New York; 1989.
• [10]Akhter MP, Raab DM, Turner CH, Kimmel DB, Recker RR. Characterization of invivo strain in the rat tibia during external application of a four-point bending load. J Biomech. 1992; 25(10):1241-1246.
• [11]Turner CH, Akhter MP, Raab DM, Kimmel DB, Recker RR. A noninvasive, in vivo model for studying strain adaptive bone modeling. Bone. 1991; 12(2):73-79.
• [12]Raabcullen DM, Akhter MP, Kimmel DB, Recker RR. Periosteal bone formation stimulated by externally induced bending strains. J Bone Miner Res. 1994; 9(8):1143-1152.
• [13]Raab-Cullen DM, Akhter MP, Kimmel DB, Recker RR. Bone response to alternate-day mechanical loading of the rat tibia. J Bone Miner Res. 1994; 9(2):203-211.
• [14]Hagino H, Raab DM, Kimmel DB, Akhter MP, Recker RR. Effect of ovariectomy on bone response to invivo external loading. J Bone Miner Res. 1993; 8(3):347-357.
• [15]Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ et al.. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2(6):595-610.
• [16]Cullen DM, Smith RT, Akhter MP. Time course for bone formation with long-term external mechanical loading. J Appl Physiol. 2000; 88(6):1943-1948.
• [17]Hagino H, Okano T, Akhter MP, Enokida MTR. Effect of parathyroid hormone on cortical bone response to in vivo external loading of the rat tibia. J Bone Miner Metab. 2001; 19:244-250.
• [18]Foldes J, Shih MS, Parfitt AM. Frequency-distributions of tetracycline measurements - imprication for the interpretaion of bone-formation indexes int the absence of double-labeled surfaces. J Bone Miner Res. 1990; 5(10):1063-1067.
• [19]Kameyama Y, Hagino H, Okano T, Enokida M, Fukata S, Teshima R. Bone response to mechanical loading in adult rats with collagen-induced arthritis. Bone. 2004; 35(4):948-956.
• [20]Galli C, Passeri G, Macaluso GM. Osteocytes and WNT: the mechanical control of bone formation. J Dent Res. 2010; 89(4):331-343.
• [21]Mosley JR, Lanyon LE. Strain rate as a controlling influence on adaptive modeling in response to dynamic loading of the ulna in growing male rats. Bone. 1998; 23(4):313-318.
• [22]Hagino H, Kuraoka M, Kameyama Y, Okano T, Teshima R. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading. Bone. 2005; 36(3):444-453.
• [23]Nagira K, Hagino H, Kameyama Y, Teshima R: Effects of minodronate on cortical bone response to mechanical loading in rats. Bone. 2013;53(1):277–83.
• [24]Hagino H. Eldecalcitol: newly developed active vitamin D3 analog for the treatment of osteoporosis. Expert Opin Pharmacother. 2013; 14(6):817-825.
• [25]Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S et al.. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998; 95(7):3597-3602.
• [26]Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T, Sekine K et al.. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology. 2013; 154(3):1008-1020.
• [27]Yamane K, Okano T, Kishimoto H, Hagino H. Effect of ED-71 on modeling of bone in distraction osteogenesis. Bone. 1999; 24(3):187-193.
• [28]Uysal T, Amasyali M, Enhos S, Sonmez MF, Sagdic D. Effect of ED-71, a New Active Vitamin D Analog, on Bone Formation in an Orthopedically Expanded Suture in Rats. A Histomorphometric Study. European journal of dentistry. 2009; 3(3):165-172.
• [29]Saito H, Takeda S, Amizuka N. Eldecalcitol and calcitriol stimulates ‘bone minimodeling’, focal bone formation without prior bone resorption, in rat trabecular bone. J Steroid Biochem Mol Biol. 2013; 136:178-182.
• [30]de Freitas PH, Hasegawa T, Takeda S, Sasaki M, Tabata C, Oda K et al.. Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in trabecular bone of ovariectomized rats. Bone. 2011; 49(3):335-342.
• [31]Shiraishi A, Sakai S, Saito H, Takahashi F: Eldecalcitol improves mechanical strength of cortical bones by stimulating the periosteal bone formation in the senescence-accelerated SAM/P6 mice - A comparison with alfacalcidol. J Steroid Biochem Mol Biol. 2014;144 Pt A:119–23.
• [32]Sankaralingam A, Roplekar R, Turner C, Dalton RN, Hampson G. Changes in Dickkopf-1 (DKK1) and Sclerostin following a Loading Dose of Vitamin D 2 (300,000 IU). J Osteoporos. 2014; 2014:682763.
• [33]Dawson-Hughes B, Harris SS, Ceglia L, Palermo NJ. Effect of supplemental vitamin D and calcium on serum sclerostin levels. European journal of endocrinology/European Federation of Endocrine Societies. 2014; 170(4):645-650.